SEC Form 4 · accession 0001606498-17-000029
AVANOS MEDICAL, INC. · AVNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert E Abernathy
Officer — President and CEO
Period of report
May 3, 2017
Accepted (ET)
May 5, 2017 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001606498
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $36.74 | May 3, 2017 | A | 134,680 | A | — | May 3, 2027 | Common Stock | 134,680 | 134,680 | D |
Explanation of responses
- F1The awards vest 30% on May 3, 2018, 30% on May 3, 2019 and 40% on May 3, 2020, subject to earlier vesting in the event of death, disability or certain other events.